Claims for Patent: 6,686,444

Summary for Patent: 6,686,444

Title:	Osteopontin derived chemotactic peptides and methods of use
Abstract:	Novel osteopontin derived chemotactic peptides are described. The peptides (or antagonists thereof) are useful in treating conditions or diseases associated with chemotaxis.
Inventor(s):	Ashkar; Samy (Boston, MA)
Assignee:	Children\'s Medical Center Corporation (Boston, MA)
Application Number:	08/918,189
Patent Claims:	1. A purified peptide consisting of the amino acid sequence LVLDPK (SEQ ID NO:1). 2. A purified peptide consisting of the amino acid sequence VLDPK (SEQ ID NO:7). 3. A purified peptide consisting essentially of a sequence selected from the group consisting of LVLDPK (SEQ ID NO:1), LVVDPK (SEQ ID NO:3), LVPDPK (SEQ ID NO:4), LVPDSK (SEQ ID NO:5) and LVIDPK (SEQ ID NO:6, wherein the peptide consists of between 6 and 60 amino acids, wherein the peptide has chemotactic activity. 4. A purified peptide comprising 60 amino acids or less and the sequence VLDPK (SEQ ID NO:7), said peptide having chemotactic activity. 5. A composition comprising an amount of the peptide of claim 3 or 4 suitable to effect chemotaxis of cells bearing receptors that recognize the peptide and pharmaceutically-acceptable carrier or diluent. 6. The composition of claim 5, wherein said carrier is a matrix. 7. The composition of claim 6, wherein said matrix is selected from the group consisting of fibrin, collagen, gelatin and agarose. 8. The composition of claim 5, wherein said carrier or diluent is selected from the group consisting of albumin, sterile water, polyethylene glycol and saline. 9. The composition of claim 5, wherein said composition includes an adjuvant. 10. A purified peptide consisting of an amino acid sequence selected from the group consisting of LVLDPK (SEQ ID NO:1), LVVDPK (SEQ ID NO:3), LVPDPK (SEQ ID NO:4), LVPDSK (SEQ ID NO:5), LVIDPK (SEQ ID NO:6) and VLDPK (SEQ ID NO:7). 11. A purified peptide consisting of the amino acid sequence KFHSHKDKLVLDPKSK (SEQ ID NO:2). 12. A purified chemotactic peptide which consists of the amino acid sequence VLDPK (SEQ ID NO:7). 13. A composition comprising the peptide of claim 3 in an amount suitable to effect chemotaxis and a pharmaceutically-acceptable carrier or diluent. 14. The composition of claim 13, wherein said carrier is a matrix. 15. The composition of claim 14, wherein said matrix is selected from the group consisting of fibrin, collagen, gelatin and agarose.

Details for Patent 6,686,444

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2016-08-22